Valuation: Cutia Therapeutics

Market Cap 833M 963M 123M 107M 99.09M 91.52M 174M 11.71B 177M 1.18B 465M 5.77B 461M 451M 19.84B P/E 2026 *
-5x
P/E 2027 * 17.6x
Enterprise Value 901M 1.04B 133M 116M 107M 99.07M 188M 12.68B 191M 1.28B 503M 6.25B 499M 488M 21.48B EV / Sales 2026 *
1.4x
EV / Sales 2027 * 0.71x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.49%
1 week-3.28%
Current month-6.36%
1 month-21.36%
3 months-42.52%
6 months-49.04%
Current year-41.63%
1 week 2.57
Extreme 2.57
2.88
1 month 2.57
Extreme 2.57
3.41
Current year 2.57
Extreme 2.57
5.51
1 year 2.57
Extreme 2.57
12
3 years 2.57
Extreme 2.57
31
5 years 2.57
Extreme 2.57
32.6
10 years 2.57
Extreme 2.57
32.6
Manager TitleAgeSince
Chief Executive Officer 48 01/09/2019
Director of Finance/CFO 36 10/05/2021
Chief Tech/Sci/R&D Officer 42 10/01/2020
Director TitleAgeSince
Director/Board Member 48 12/05/2020
Chairman 63 23/08/2019
Director/Board Member 36 15/11/2022
Date Insider Type Main position Quantity % Market Cap.
15/10/24Other

Founder

15,000 0.0049%
03/10/24Other

Chief Financial Officer

20,000 0.0066%
02/10/24Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-3.28%-69.43%-88.20% 123M
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.21%-3.25%+17.11%+42.21% 357.4B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.90%

Financials

2026 *2027 *
Net sales 646M 747M 95.26M 83.32M 76.85M 70.98M 135M 9.08B 137M 918M 361M 4.48B 358M 350M 15.39B 1.18B 1.36B 174M 152M 140M 130M 246M 16.59B 250M 1.68B 659M 8.18B 653M 639M 28.1B
Net income -146M -169M -21.49M -18.8M -17.34M -16.02M -30.39M -2.05B -30.9M -207M -81.36M -1.01B -80.7M -78.94M -3.47B 44.25M 51.16M 6.53M 5.71M 5.27M 4.86M 9.23M 622M 9.38M 62.91M 24.7M 307M 24.5M 23.97M 1.05B
Net Debt 68.7M 79.43M 10.13M 8.86M 8.17M 7.55M 14.33M 966M 14.57M 97.67M 38.36M 476M 38.04M 37.21M 1.64B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
10/07/26 HK$2.650 -1.49% 23,000
09/07/26 HK$2.690 +1.51% 37,800
08/07/26 HK$2.650 0.00% 9,600
07/07/26 HK$2.650 -5.69% 180,600
06/07/26 HK$2.810 +2.55% 8,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.292CNY
Average target price
9.801CNY
Spread / Average Target
+327.65%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock